Microkeratome Market: By Application (Epiretinal Membrane, Diabetic Retinopathy, Retinal Detachment, and Others), By Product (Disposable and Reusable), By End User (Hospitals, Ophthalmology Centers, and Others), and Geography     

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Microkeratome Market size was valued at USD 678.90 million in 2021 and is expected to reach USD 1876.72 million by 2028, at a CAGR of 10.0% during the forecast period 2022-2028. A microkeratome is a high-precision surgical equipment that consists of an oscillating blade that is used to generate the corneal flap for refractive surgery, and is particularly useful in ALK and LASIK procedures. A healthy human cornea is approximately 500 and 600 millimetres thick. The microkeratome forms an 83200 m thick flap in the LASIK procedure. Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) uses a microkeratome to cut a reedy layer from the back of the cornea, which is subsequently moved into the inheritor's cornea. The vacuum and microkeratome units are built, thoroughly tested, and examined prior to the start of surgery to ensure proper operation. this report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global Microkeratome Market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Microkeratome Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).

Key Development:
In February 2017, Johnson & Johnson completed the acquisition of Abbott Medical Optics.

Microkeratome Market Summary

Study Period


Base Year




Largest Market


Fastest Growing Market

Microkeratome Market

The increasing development of the geriatric population and the rise in the prevalence of eye problems are driving the global microkeratome market. Furthermore, technical developments in surgical devices are a major driver of market growth.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Microkeratome Market Segmentation

By Product
  • Disposable
  • Reusable
By Application
  • Epiretinal Membrane
  • Diabetic Retinopathy
  • Retinal Detachment
  • Others
By End User
  • Hospitals
  • Ophthalmic Centers
  • Others

Frequently Asked Questions

The microkeratome market is projected to expand at a CAGR of 10.0% during the forecast period.

Europe is the fastest-growing region for microkeratome market

Alcon, Inc., Johnson & Johnson Vision Care, CooperVision, Bausch & Lomb Incorporated, Essilor International

  • Alcon, Inc. (U.S)
  • Johnson & Johnson Vision Care (U.S)
  • CooperVision (U.S)
  • Bausch & Lomb Incorporated (U.S)
  • Essilor International (France)
  • Hoya Corporation (Japan)
  • Carl Zeiss AG (Germany)